Role of molecular diagnostics in the clinical management of SARS-CoV-2 infection: advantages and drawbacks

Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):49-51. doi: 10.37201/req/s01.15.2021. Epub 2021 Sep 30.

Abstract

The diagnosis of SARS-CoV-2 is based on the use of nucleic acid amplification tests (NAAT), especially rRT-PCR. The latter also allows us to quickly identify variants of concern. However, its use in follow-up of patients and the correlation between Ct value and the viability of the virus is controversial.

Publication types

  • Review

MeSH terms

  • COVID-19 Testing
  • COVID-19*
  • Humans
  • Pathology, Molecular
  • SARS-CoV-2*